You are here

Article Text

Article menu
Download PDFPDF
Letters to the editor
IUD/IUS insertions and atropine
  1. Jane Dickson1,
  2. Asha Kasliwal2 and
  3. Sarah Randall3
  1. Vice Chair, FSRH Clinical Standards Committee, London, UK; jane.dickson@nhs.net
  2. Chair, FSRH Clinical Standards Committee, London, UK; asha.kasliwal@manchester.nhs.uk
  3. Chair, FSRH Associate Members' Working Group, London, UK

https://doi.org/10.1136/jfprhc.2011.0086

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read with interest the correspondence relating to intrauterine device (IUD)/intrauterine system (IUS) insertions and atropine. This letter aims to provide an understanding of how this guidance was developed.

    The Clinical Standards Committee is responsible for providing guidance on clinical governance in the form of auditable standards to enable the provision of high-quality patient-centred care. There is no division within the Standards between that which should be provided by a doctor or by a nurse, unless there is a clinician-specific issue, for example, issuing medication under a patient group direction (PGD) for non-prescribers.

    The updated Resuscitation Standard of the Faculty of Sexual and Reproductive Healthcare was published in November 2010.1 Work began on updating the document in January 2010 and …

    View Full Text

    Footnotes

    • Competing interests None.